Evidence map›Paper›PMID 30496172›Full record

ArticlePLoS neglected tropical diseases2018

Integrating evidence, models and maps to enhance Chagas disease vector surveillance.

Alexander Gutfraind, Jennifer K Peterson, Erica Billig Rose, Claudia Arevalo-Nieto, Justin Sheen, Gian Franco Condori-Luna, Narender Tankasala, Ricardo Castillo-Neyra, Carlos Condori-Pino, Priyanka Anand and 2 more

Abstract read
In one paragraph

Article in PLoS neglected tropical diseases, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed.

  1. Trial
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Risk maps for cities: Incorporating streets into geostatistical models.Spatial and spatio-temporal epidemiology · 2018
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Alexander GutfraindLaboratory for Mathematical Analysis of Data, Complexity and Conflicts, Division of Epidemiology and Biostatistics, University of Illinois at Chicago, Chicago, IL, United States of America.
Jennifer K PetersonDepartment of Biostatistics, Epidemiology & Informatics; Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, United States of America.ORCID 0000-0002-0274-6143
Erica Billig RoseDepartment of Biostatistics, Epidemiology & Informatics; Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, United States of America.
Claudia Arevalo-NietoZoonotic Disease Research Laboratory, One Health Unit, Facultad de Salud Pública y Administración, Universidad Peruana Cayetano Heredia, Lima, Perú.ORCID 0000-0002-3701-193X
Justin SheenDepartment of Biostatistics, Epidemiology & Informatics; Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, United States of America.
Gian Franco Condori-LunaZoonotic Disease Research Laboratory, One Health Unit, Facultad de Salud Pública y Administración, Universidad Peruana Cayetano Heredia, Lima, Perú.
Narender TankasalaLaboratory for Mathematical Analysis of Data, Complexity and Conflicts, Division of Epidemiology and Biostatistics, University of Illinois at Chicago, Chicago, IL, United States of America.
Ricardo Castillo-NeyraDepartment of Biostatistics, Epidemiology & Informatics; Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, United States of America.
Carlos Condori-PinoZoonotic Disease Research Laboratory, One Health Unit, Facultad de Salud Pública y Administración, Universidad Peruana Cayetano Heredia, Lima, Perú.
Priyanka AnandDepartment of Biostatistics, Epidemiology & Informatics; Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, United States of America.
Cesar Naquira-VelardeZoonotic Disease Research Laboratory, One Health Unit, Facultad de Salud Pública y Administración, Universidad Peruana Cayetano Heredia, Lima, Perú.
Michael Z LevyDepartment of Biostatistics, Epidemiology & Informatics; Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, United States of America.

Funding

Disrupting Vector-borne Disease Transmission in Complex Urban EnvironmentsR01AI101229 · NIAID · UNIVERSITY OF PENNSYLVANIA · PI LEVY, MICHAEL Z · 2013 to 2017
$3.1M
NIAID NIH HHS R01 AI101229
6 · The paper itself

Abstract

backgroundUntil recently, the Chagas disease vector, Triatoma infestans, was widespread in Arequipa, Perú, but as a result of a decades-long campaign in which over 70,000 houses were treated with insecticides, infestation prevalence is now greatly reduced. To monitor for T. infestans resurgence, the city is currently in a surveillance phase in which a sample of houses is selected for inspection each year. Despite extensive data from the control campaign that could be used to inform surveillance, the selection of houses to inspect is often carried out haphazardly or by convenience. Therefore, we asked, how can we enhance efforts toward preventing T. infestans resurgence by creating the opportunity for vector surveillance to be informed by data? METHODOLOGY/PRINCIPAL

findingsTo this end, we developed a mobile app that provides vector infestation risk maps generated with data from the control campaign run in a predictive model. The app is intended to enhance vector surveillance activities by giving inspectors the opportunity to incorporate the infestation risk information into their surveillance activities, but it does not dictate which houses to surveil. Therefore, a critical question becomes, will inspectors use the risk information? To answer this question, we ran a pilot study in which we compared surveillance using the app to the current practice (paper maps). We hypothesized that inspectors would use the risk information provided by the app, as measured by the frequency of higher risk houses visited, and qualitative analyses of inspector movement patterns in the field. We also compared the efficiency of both mediums to identify factors that might discourage risk information use. Over the course of ten days (five with each medium), 1,081 houses were visited using the paper maps, of which 366 (34%) were inspected, while 1,038 houses were visited using the app, with 401 (39%) inspected. Five out of eight inspectors (62.5%) visited more higher risk houses when using the app (Fisher's exact test, p < 0.001). Among all inspectors, there was an upward shift in proportional visits to higher risk houses when using the app (Mantel-Haenszel test, common odds ratio (OR) = 2.42, 95% CI 2.00-2.92), and in a second analysis using generalized linear mixed models, app use increased the odds of visiting a higher risk house 2.73-fold (95% CI 2.24-3.32), suggesting that the risk information provided by the app was used by most inspectors. Qualitative analyses of inspector movement revealed indications of risk information use in seven out of eight (87.5%) inspectors. There was no difference between the app and paper maps in the number of houses visited (paired t-test, p = 0.67) or inspected (p = 0.17), suggesting that app use did not reduce surveillance efficiency. CONCLUSIONS/SIGNIFICANCE: Without staying vigilant to remaining and re-emerging vector foci following a vector control campaign, disease transmission eventually returns and progress achieved is reversed. Our results suggest that, when provided the opportunity, most inspectors will use risk information to direct their surveillance activities, at least over the short term. The study is an initial, but key, step toward evidence-based vector surveillance.

Indexed as

Animal DistributionAnimalsChagas DiseaseEpidemiological MonitoringHumansInsect ControlInsecticidesInsect VectorsPeruPilot ProjectsTriatomaInsecticides

Identifiers

PMID30496172
PMCPMC6289469

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.